Dr. Njideka Emily Orimilikwe, MD

Dr. Orimilikwe practices at Adena Dialysis in Pompano Beach, Florida.

Dr. Orimilikwe's NPI, 1750549309, was assigned on May 30, 2008. Dr. Orimilikwe holds Ohio license 35.092032.

Dr. Orimilikwe's primary practice is Adena Dialysis, at 3890 Park Central N Blvd, Pompano Beach, FL 33064 in Broward County. The practice phone is (740) 773-3733.

Dr. Orimilikwe's primary practice is Adena Dialysis in Pompano Beach, Florida. Dr. Orimilikwe is also affiliated with Adena Regional Medical Center. The medical group on file is Adena Health System. Dmand AI also links Dr. Orimilikwe to 4 more hospitals, 4 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Orimilikwe practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Orimilikwe's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Orimilikwe's licenses on file in 2 states: Ohio and New York.

CMS data shows 1,508 Medicare services from Dr. Orimilikwe across 8 procedure codes in 2024, for 413 Medicare patients. Medicare paid $103,617 for them.

CMS counts 413 Medicare patients who saw Dr. Orimilikwe in 2024. The largest group is 75 to 84, with 154 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 20% are also on Medicaid. Their average risk score is 3.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Orimilikwe's median patient age at 74, with 57% women.

In 2024, Dr. Orimilikwe wrote 1,614 Medicare Part D claims for 285 patients. 89% of them were for generic drugs. CMS names the drug for 1,306 of them, across 35 drugs with 11 or more claims each, at $145,424 in total drug cost. In 2023, CMS named 1,171 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Orimilikwe for performance year 2024, reported as part of a group. Dr. Orimilikwe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Orimilikwe as offering telehealth.

CMS Open Payments shows 238 general payments to Dr. Orimilikwe from 32 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 92% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $1,443.